23andMe lays off 40% of workers, reports losses amid uncertain future
( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass layoffs — 40% of the company’s workforce — and declining sales. The biotech company, which collects consumers’ voluntarily submitted saliva in testing kits, announced the layoffs on Monday, impacting more than 200 employees.